Cite
HARVARD Citation
Pinget, M. et al. (n.d.). Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone (GetGoal‐P). Diabetes, obesity & metabolism. 15 (11), pp. 1000-1007. [Online].